Sizzling Volume Gainers: Cord Blood America Inc. (OTC:CBAI), Bebida Beverage Company (PINK:BBDA), A123 Systems Inc. (PINK:AONEQ), RXi Pharmaceuticals Corp (OTC:RXII)

Stamford, CT -- (SBWIRE) -- 03/15/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Best Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

Cord Blood America Inc. (OTC:CBAI) stock is at $0.0031, down-16.22 percent from its previous close of $0.0037. The stock opened the session at $0.0035 and touched its highest price point at $0.0038. CBAIstock’s lowest price point for the session stood at $0.003.

Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive+34.78% during the previous three months trade.

Its total trading volume is 11.97 million shares for the day, in comparison to its average trading volume of 23.62 million shares.Cord Blood America Inc through its subsidiaries, provides private cord blood stem cell preservation services to families throughout the United States and internationally in South America, China, Germany, and Spain.

Will CBAIGet Buyers Even After The Recent Rally? Find Out Here

Bebida Beverage Company(PINK:BBDA) stock is at $0.0039, down -2.50 percent from its previous close of $0.004. Its today’s volume is 11.49 million shares, in comparison to its average trading volume of 14.01 million shares. The stock opened the session at $0.0039 and touched its highest price point at $0.0042.

BBDA’s lowest price point for the session stood at $0.0039 and its 52 week price range stood at $0.0003 - $0.0199. The company has a total of 11.49 million outstanding shares and its total market capitalization is $14.1 million. Its beta value stands at -3.86 times.Bebida Beverage Companya developer, manufacturer and marketer of liquid relaxation and energy products, announced that the company has partnered with Tommy's Food Stores, Inc. for placement of BeBevCo's Flagship Product, KOMA Unwind.

Has BBDA Found The Bottom and Ready To Move Up? F ind Out Here

A123 Systems, Inc.(PINK:AONEQ) opened the session at $0.02 and remained in the $0.02 to $0.03 price range during the session. The stock is +3.20 percent higher,at $0.0258. Volume closed the day at 10.57 million shares, its average volume being 5.52 million shares.

The company has a total of 5.21 million outstanding shares and its total market capitalization is $5.21 million. Its beta value stands at2.37 times and earnings per share was -$2.60.

AONEQwas a loser in the 5 days activity and slipped about -4.09%. The one month performance of the stock was negative and it plunged more than -4.09%.A123 Systems, Inchas completed the sale of substantially all of its assets to Wanxiang America Corporation and Navitas Systems LLC that was approved by the United States Bankruptcy Court for the District of Delaware.

Why Should Investors Buy AONEQ After the Recent Fall? Just Go Here and Find Out

RXi Pharmaceuticals Corp (OTC:RXII) traded in the range of $0.30 and $0.36 in its previous trading session. The stock recorded the volume of 9.32 million shares, in comparison to its average daily trading volume of 1.15 million shares.

Company’s year to date performance remained optimistic with the rise of +340%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of +200%. The stock opened at $0.30 and its closing price for the day was $00.330, up+13.79 percent from its previous close of $0.29.RXi Pharmaceuticals Corpa biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, announced that the Company’s President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 25th Annual ROTH Conference on Tuesday, March 19th at 1:30pm PT. Dr. Cauwenbergh will discuss the development of RXI-109, a self-delivering RNAi compound designed to reduce dermal scarring, as well as business development opportunities with RXi’s sd-rxRNA® technology platform.

For How Long RXII’s Gloss will Attract Investors? Find out via this report

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.